Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: All you need to know about Pfizer’s Q4 2021 earnings results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today.
Revenues doubled year-over-year to $23.8 billion. Excluding contributions from Comirnaty and Paxlovid, revenues dropped 2% operationally, driven mainly by the impact of fewer selling days compared to the prior-year quarter.
On a reported basis, net income jumped to $3.3 billion, or $0.59 per share, from $847 million, or $0.15 per share, last year. Adjusted net income more than doubled to $6.2 billion, or $1.08 per share, versus last year.
For full-year 2022, revenues are expected to range between $98-102 billion while adjusted EPS is estimated to range between $6.35-6.55.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: How Lennar (LEN) performed in Q4 2025
Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the fourth quarter of 2025, compared to $9.9 billion reported in the same period a year ago. Net earnings
Paychex expected to report higher revenue and earnings for Q2 FY26
Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the
Signet Jewelers (SIG): A look at the progress made on Grow Brand Love
Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,
